Lorettta M Itri - Net Worth and Insider Trading

Lorettta M Itri Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Lorettta M Itri owns 2 companies in total, including Immunomedics Inc (IMMU) , and Aadi Bioscience Inc (AADI) .

Click here to see the complete history of Lorettta M Itri’s form 4 insider trades.

Insider Ownership Summary of Lorettta M Itri

Ticker Comapny Transaction Date Type of Owner
IMMU Immunomedics Inc 2020-02-13 Chief Medical Officer
AADI Aadi Bioscience Inc 2021-10-21 Chief Medical Officer

Lorettta M Itri Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Lorettta M Itri Ownership Network

Ownership Network List of Lorettta M Itri

No Data

Ownership Network Relation of Lorettta M Itri


Lorettta M Itri Owned Company Details

What does Immunomedics Inc do?

Who are the key executives at Immunomedics Inc?

Lorettta M Itri is the Chief Medical Officer of Immunomedics Inc. Other key executives at Immunomedics Inc include director & 10 percent owner & other: See Remarks Venbio Select Advisor Llc , director & 10 percent owner & other: See Remarks Behzad Aghazadeh , and director & President and CEO Harout Semerjian .

Immunomedics Inc (IMMU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Immunomedics Inc (IMMU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immunomedics Inc (IMMU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Immunomedics Inc (IMMU)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Immunomedics Inc Insider Transactions

No Available Data

Lorettta M Itri Mailing Address

Above is the net worth, insider trading, and ownership report for Lorettta M Itri. Currently GuruFocus does not have mailing address information for Lorettta M Itri.

Discussions on Lorettta M Itri

No discussions yet.